择期腹主动脉瘤腔内修复术后出院时II型内漏的发生率、再干预与生存:血管质量倡议分析
基于血管质量倡议2010-2020年择期肾下腹主动脉瘤腔内修复术数据,出院时孤立性II型内漏发生率为16%。校正后II型内漏与无内漏组生存相似(HR 0.95,95%CI 0.9-1.0)。1年随访中II型内漏再干预率12%,再干预与未再干预者5年生存相似(89% vs 91%,log-rank P=0.06)。
要点
- 出院时孤立性II型内漏发生率为16%,住院死亡率低于无内漏组(0.8% vs 1.9%)。
- 风险校正后II型内漏与无内漏组总体生存相似(HR 0.95,95%CI 0.9-1.0)。
- II型内漏再干预率为12%,再干预与未再干预者5年生存相似(89% vs 91%,P=0.06)。
核心结论
- 在血管质量倡议中,II型内漏在EVAR后仍常见,且与长期死亡率无关。
- 针对II型内漏的再干预与总体生存改善无关。
- II型内漏的自然病程似乎为良性,但关于再干预适当作用的数据仍需要。
研究设计与样本
- 回顾性分析血管质量倡议2010-2020年所有择期EVAR病例,比较出院时孤立性II型内漏与无内漏患者,排除I型或III型内漏。
- 共纳入53,697例EVAR患者;另对存活超过术后第一年且有内漏随访数据的44,345例患者行亚组分析。
- 主要结局为总体生存,次要结局为围术期死亡和再干预,采用多变量logistic回归和Cox比例风险回归校正协变量。
主要发现
- 出院时孤立性II型内漏总体发生率为16%。
- 住院死亡率II型内漏组 vs 无内漏组为0.8% vs 1.9%(OR 0.6,95%CI 0.5-0.8,P<.0001)。
- 未校正5年总体生存II型内漏组 vs 无内漏组为84% vs 82%,风险校正后生存相似(HR 0.95,95%CI 0.9-1.0)。
- 44,345例1年随访患者中66%有内漏状态数据,无论内漏状态如何生存相似。
- 随访中记录II型内漏者中,6.1%和2.5%分别出现腹主动脉瘤囊直径增长≥5 mm和≥10 mm;再干预发生率为12%,破裂(1%)和任何开放再干预(4%)罕见。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The longitudinal clinical significance of type II endoleaks (T2ELs) remains controversial. Specifically, the real-world incidence, need for reintervention, and associated mortality referable to T2ELs remain unknown. Moreover, current professional society clinical practice guidelines recommend differing aneurysm sac growth thresholds to prompt intervention. Therefore, the purpose of this analysis was to better quantify the prevalence of early T2ELs after infrarenal endovascular aortic aneurysm repair (EVAR) and determine its association with reintervention and survival. METHODS: All elective EVARs from the Vascular Quality Initiative (2010-2020) were examined to identify patients with isolated T2ELs vs no endoleak (NONE) at discharge. Procedures with a type I or III endoleak were excluded. A subgroup analysis was performed on patients surviving beyond the first postoperative year with follow-up data available on endoleaks. The primary outcome was overall survival. Secondary outcomes included perioperative mortality and reinterventions. Outcomes were assessed by multivariable logistic and Cox proportional hazards regression to adjust for covariates. RESULTS: We identified 53,697 patients who underwent EVAR. The overall incidence of isolated T2ELs at discharge was 16%. In-hospital mortality was lower for those with isolated T2ELs vs NONE (0.8% vs 1.9%, odds ratio: 0.6, 95% confidence interval: 0.5-0.8, P < .0001). Unadjusted overall survival was marginally higher at 5 years for patients with T2ELs vs NONE (84% vs 82%); however, after risk adjustment, survival was similar (hazard ratio: 0.95, 95% confidence interval: 0.9-1.0). Among 44,345 patients with 1-year follow-up, 66% had data on endoleak status for assessment. Survival was similar regardless of endoleak status (NONE, at discharge only, at follow-up only, or at both time points). Among patients with documented T2ELs during follow-up, 6.1% and 2.5% had abdominal aortic aneurysm sac diameter growth ≥5 mm and ≥10 mm, respectively. Reinterventions occurred in 12%. Rupture (1%) and any open reintervention (4%) were rare among patients with 1-year follow-up. For patients with T2ELs, 5-year survival was similar between those with and without reintervention by 1 year (89% vs 91%, log-rank P = .06). CONCLUSIONS: T2ELs remain common after EVAR within the Vascular Quality Initiative and are not associated with long-term mortality. Reinterventions for T2ELs were not associated with improved overall survival among patients with T2ELs. Although additional data surrounding the appropriate role of reintervention for T2ELs remain necessary, it appears that the natural history of T2ELs is benign.
引用
- DeMartino RR, Breite MD, Neal D, et al. Incidence, reintervention, and survival associated with type II endoleak at hospital discharge after elective endovascular aneurysm repair in the Vascular Quality Initiative. J Vasc Surg. 2023. PMID: 37257671. doi:10.1016/j.jvs.2023.05.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。